COVID-19: A Message from Our CEO
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited
CSL Behring Gene Therapy Agreement with uniQure
Unique gene therapy has the potential to be one of the first to market treatments to provide potentially long-term benefits w…
Get to Know Us Better
Senior Manager, ASQ Group Leader External Materials & Sampling (Marburg, Germany)
Angelika has been with CSL Behring for nearly 20 years and in that time has grown from having no direct reports to leading a large team in our Quality group.